Medesthetics

JUL-AUG 2018

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link: https://medesthetics.epubxp.com/i/995786

Contents of this Issue

Navigation

Page 63 of 68

medestheticsmagazine.com | JULY/AUGUST 2018 61 of business development and general manager of Laboratoire Dr. Renaud, which was acquired by Crescita in 2016. Isabelle Villeneuve, former senior director of R&D and head of the International Center of Excellence in Skincare at Valeant Pharmaceuticals, has joined Crescita as vice president of strategy, quality and innovation. Villeneuve also worked for Laboratoire Dr. Renaud from 1995 to 2016. "We are delighted to welcome Isabelle as part of our leadership team at such a pivotal time in the company's his- tory," Verreault says. "Her passion and strong dual expertise in science and product innovation will help strengthen our nonprescription skincare brands and will greatly contribute to making Crescita a North American dermo-cosmetic leader." NEW PATIENT FOLLOW-UP TOOL eRelevance Corporation, a company that provides patient en- gagement technologies and services for medical practices, has launched a new service called "Response Follow-up" to help practices manage prospective patients who have reached out to their offi ces in response to promotions and marketing cam- paigns. The service combines phone, email and text follow-up. "This new follow-up service quickly bridges the gap from pa- tient and prospect interest to converted revenue for an end-to- end solution. It ensures our clients don't miss out on that crucial window when someone is highly interested in scheduling an ap- pointment," says eRelevance co-founder and CEO, Bob Fabbio. Adds Barry DiBernardo, MD, whose plastic surgery practice was a beta tester for the new service: "We've seen dramati- cally improved results from the follow-up service because we're making contact with people we just didn't have the resources to reach on our own. We're now converting more requests to ap- pointments and ultimately revenue." SCITON ADDS NEW DATES TO BRIGHT LIGHTS BIG CITY TOUR Laser manufacturer Sciton is extending its Bright Lights Big City BBL Tour hosted by Dr. Patrick Bitter Jr., creator of the Fotofa- cial. The new 2018 events will include Chicago, New York City, Austin, Texas, and Washington, D.C. The seminars were created to help clinicians achieve optimal results with the company's BBL (BroadBand Light), a high- energy output intense pulsed light device that offers multiple fi lters to address a variety of aesthetic concerns. "One of my greatest passions is creating clearer, smoother, healthier, younger-looking skin for my patients with Fotofacial treatments using BBL. And one of my greatest rewards is shar- ing how to best use BBL with my colleagues," says Dr. Bitter. "Teaching my colleagues how to master BBL to get the same patient-pleasing results as I brings me great satisfaction." Upcoming seminars include: July 28, Chicago September 22, New York City October 6, Austin, Texas November 16, Washington, D.C. To register, visit sciton.com/bright-lights-big-city-tour/ SILVERNAIL JOINS EVOLUS AS CFO Lauren Silvernail, former chief fi nancial offi cer (CFO) and chief business offi cer at Revance Therapeu- tics, is now the CFO and executive vice president of corporate development at Evolus. Prior to her time at Revance, Silvernail served as CFO and VP of corpo- rate development at ISTA Pharmaceuticals. She joins the company as it works towards approval of its prabotulinumtoxinA injectable (DWP- 450) for the treatment of moderate-to-severe glabellar lines. "I welcome Lauren to Evolus as her appointment further strengthens our executive leadership team and represents a critical milestone for the company ahead of commercializa- tion," said David Moatazedi, president and CEO of Evolus. "Lauren brings extensive category experience and deep fi nancial, operational, commercial and corporate development expertise as we prepare to bring our fi rst product candidate to market.Ó ASJ TO LAUNCH OPEN ACCESS JOURNAL The Aesthetic Surgery Journal (ASJ) in conjunction with Oxford University Press will begin publishing an open access publica- tion (a restriction- and subscription-free online research jour- nal), titled Aesthetic Surgery Journal Open Forum in January 2019. The new journal will utilize the same editorial team as ASJ, with Foad Nahai, MD, as editor-in-chief, and Jeffrey Kenkel, MD, professor and chairman of the plastic surgery department of UT Southwestern, as associate editor. Dr. Nahai notes Lauren Silvernail CORRECTION In the article "A Healthy Balance" in our April 2018 issue, we incorrectly referred to Dermala as a probiotic-based acne line from Johnson & Johnson. Dermala is a spinout company from the University of California, San Diego, and a resident of JLABS San Diego, a Johnson & Johnson inno- vation incubator. Its fi rst product line is for the treatment of acne. The company is also developing probiotic-based lines for eczema and skin aging.

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - JUL-AUG 2018